Ocean Biomedical, Inc.

Ocean Biomedical, Inc. completed its business combination with Aesther Healthcare Acquisition Corp (Nasdaq: AEHA), a blank-check company sponsored by Aesther Healthcare Sponsor, LLC that conducted its IPO in 2021 targeting the healthcare and life sciences sector. The Providence, Rhode Island-based biopharmaceutical company focuses on developing therapies for cancer, pulmonary fibrosis, and infectious diseases. The S-1/A amendment filed on June 15, 2023 constitutes a post-merger registration statement for the combined entity, which subsequently traded under the ticker OCEA on Nasdaq. The de-SPAC transaction brought Ocean Biomedical's preclinical and clinical-stage pipeline into the public markets. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal analytics on AEHA and thousands of other SPACs.